NAVI
35
-8
WEC
31
-5
XYL
25
-8
MAT
41
-4
DGX
22
-6
OKE
55
-6
AMP
43
-3
JCI
37
-7
WDC
38
-4
ADT
12
-5
PRU
33
-11
GM
47
-3
ADSK
59
-3
MCO
64
-7
KLAC
49
-8
GME
56
-9
PFG
17
-6
DFS
54
-8
OXY
36
-4
FTI
61
-8
NAVI
35
-8
WEC
31
-5
XYL
25
-8
MAT
41
-4
DGX
22
-6
OKE
55
-6
AMP
43
-3
JCI
37
-7
WDC
38
-4
ADT
12
-5
PRU
33
-11
GM
47
-3
ADSK
59
-3
MCO
64
-7
KLAC
49
-8
GME
56
-9
PFG
17
-6
DFS
54
-8
OXY
36
-4
FTI
61
-8
Financhill
Back

IDEXX Laboratories Quote, Financials, Valuation and Earnings

The AI Energy Miracle

Details Here.
Sell
40

IDXX
IDEXX Laboratories

Last Price:
410.38
Seasonality Move:
8.13%

7 Day Trial

ALL ACCESS PASS

$ 7

FREE REPORT: 2025 Gold Price Outlook

Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.

IDEXX Laboratories Price Quote

$410.38
-0.38 (-0.09%)
(Updated: December 19, 2024 at 2:00 PM ET)

IDEXX Laboratories Key Stats

Sell
40
IDEXX Laboratories (IDXX) is a Sell
Day range:
$410.51 - $427.14
52-week range:
$398.50 - $583.39
Dividend yield:
0%
P/E ratio:
42.45
P/S ratio:
9.29
P/B ratio:
21.61%
Volume:
542.4K
Avg. volume:
654.7K
1-year change:
-23.93%
Market cap:
$35B
Revenue:
$3.7B
EPS:
$10.37

How Much Does IDEXX Laboratories Make?

Is IDEXX Laboratories Growing As A Company?

  • What Is IDEXX Laboratories's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.07%
  • What Is IDEXX Laboratories's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.11%

IDEXX Laboratories Stock Price Performance

What Is IDEXX Laboratories 52-Week High & Low?

IDEXX Laboratories Price To Free Cash Flow

Is It Risky To Buy IDEXX Laboratories?

  • How Much Debt Does IDEXX Laboratories Have?
    Total long term debt quarterly is $873.9M
  • How Much Cash Does IDEXX Laboratories Have?
    Cash and short term investments quarterly total is $308.6M
  • What Is IDEXX Laboratories’s Book Value Per Share?
    Book value per share is 19.72

Is IDEXX Laboratories Cash Flow Positive?

  • What Is IDXX Cash Flow From Operations?
    Cash flow from operations (TTM) is $916.8M
  • What Is IDEXX Laboratories’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$747.1M
  • What Is IDEXX Laboratories’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$197.7M

IDEXX Laboratories Return On Invested Capital

  • Is Management Doing A Good Job?
    IDXX return on invested capital is 35.27%
  • What Is IDEXX Laboratories Return On Assets?
    ROA measures how assets are converting to revenues and is 26.31%
  • What Is IDXX Return On Equity?
    ROE is a measure of profitability and is 57.37%

IDEXX Laboratories Earnings Date & Stock Price

IDEXX Laboratories Competitors

  • Who Are IDEXX Laboratories's Competitors?
    Below is a list of companies who compete with IDEXX Laboratories or are related in some way:
    • Bio-Rad Laboratories Inc (BIO)
    • Boston Scientific Corp (BSX)
    • Regeneron Pharmaceuticals Inc (REGN)
    • Stryker Corp (SYK)
    • Zoetis Inc (ZTS)

IDEXX Laboratories Dividend Yield

IDEXX Laboratories Analyst Estimates

YoY Growth Past Surprise
EPS: 10.67% 4.26%
Revenue: 6.56% -0.55%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 6
Sell Recommendations: 0
Price Target: 478.62
Upside from Last Price: 16.52%

Major Shareholders

  • How many IDXX shares are owned by institutional investors?
    121.2M IDXX shares are owned by institutional investors
  • How many IDXX shares are owned by insiders?
    716K IDXX shares are owned by insiders